SequelSEC

CYPHERPUNK TECHNOLOGIES INC. CYPH

Pharmaceutical Preparations · CIK 0001509745 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$1.50M
Fiscal year ended 2021-12-31
Operating income
-$41.43M
Fiscal year ended 2021-12-31
Free cash flow
Unavailable
Fiscal year ended 2021-12-31

CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported revenue of $1.50M and net income of -$40.59M for the fiscal year ended 2021-12-31. This page shows 2 annual periods of income statement, balance sheet and cash flow figures normalized from CYPHERPUNK TECHNOLOGIES INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

CYPHERPUNK TECHNOLOGIES INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2021-12-312020-12-31
Revenue$1.50M$1.50M
Cost of revenueUnavailableUnavailable
Gross profitUnavailableUnavailable
Operating income-$41.43M-$28.54M
Net income-$40.59M-$27.51M
Research & development$32.16M$20.42M
Weighted-average diluted sharesshares 85.83Mshares 59.33M
Pretax income-$40.61M-$27.52M
Income tax expense-$24.00K-$2.00K
Diluted EPS$-0.47$-0.63
Selling, general & administrativeUnavailableUnavailable
General & administrative$10.77M$9.62M
Selling & marketingUnavailableUnavailable

Balance

CYPHERPUNK TECHNOLOGIES INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2021-12-312020-12-31
Cash & equivalents$114.92M$52.07M
Total assets$117.91M$54.37M
Current assets$116.87M$52.27M
Total liabilities$10.02M$7.72M
Current liabilities$9.99M$7.37M
Total equity incl. NCI$107.89M$46.65M
Temporary (mezzanine) equityUnavailableUnavailable
InventoryUnavailableUnavailable
Accounts receivableUnavailableUnavailable
GoodwillUnavailableUnavailable
Long-term debtUnavailableUnavailable
Accounts payable$4.19M$2.72M

Cash flow

CYPHERPUNK TECHNOLOGIES INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2021-12-312020-12-31
Operating cash flow-$35.16M-$25.96M
Capital expendituresUnavailableUnavailable
Investing cash flowUnavailable$25.00K
Financing cash flow$98.04M$74.00M
Net change in cash$62.84M$48.18M
Stock-based compensation$3.69M$2.57M
Common dividends paidUnavailableUnavailable
Common share repurchasesUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailable

Derived

CYPHERPUNK TECHNOLOGIES INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2021-12-312020-12-31
Free cash flowUnavailableUnavailable
Gross marginUnavailableUnavailable
Operating margin-2761.7%-1902.6%
FCF marginUnavailableUnavailable
SBC / revenue245.7%171.5%
Current ratio11.70x7.09x
Revenue YoY growth0.0%Unavailable
Net margin-2705.8%-1834.3%
R&D / revenue2144.0%1361.5%
CapEx / revenueUnavailableUnavailable
Long-term debt / equityUnavailableUnavailable
Effective tax rateUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CYPH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-16View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-13View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.